Literature DB >> 33893083

Proteomic Analysis of Hepatocellular Carcinoma Tissues With Encapsulation Shows Up-regulation of Leucine Aminopeptidase 3 and Phosphoenolpyruvate Carboxykinase 2.

Keisuke Kuhara1,2, Takao Kitagawa1, Byron Baron3, Kazuhiro Tokuda4, Kazuhiko Sakamoto5, Hiroaki Nagano5, Kazuyuki Nakamura6, Masanobu Kobayashi1, Hiroki Nagayasu2, Yasuhiro Kuramitsu7.   

Abstract

BACKGROUND/AIM: Cancer is the most fatal disease worldwide whose most lethal characteristics are invasion and metastasis. Hepatocellular carcinoma (HCC) is one of the most fatal cancers worldwide. HCC often shows encapsulation, which is related to better prognosis. In this study, proteomic analysis of HCC tissues with and without encapsulation was performed, in order to elucidate the factors which play important roles in encapsulation.
MATERIALS AND METHODS: Five HCC tissues surrounded by a capsule and five HCC tissues which broke the capsule were obtained from patients diagnosed with HCC who underwent surgical liver resection. Protein samples from these tissues were separated by two-dimensional gel electrophoresis (2-DE), and the protein spots whose expression was different between encapsulated and non-encapsulated HCC tissues were identified through gel imaging analysis software. The selected protein spots were analyzed and identified by liquid chromatography-tandem mass spectrometry (LC-MS/MS).
RESULTS: Two-DE analysis showed 14 spots whose expression was different between encapsulated and non-encapsulated HCC tissues. Of these, 9 were up-regulated and 5 were down-regulated in HCC tissues without encapsulation. The validation by Western blot confirmed that leucine aminopeptidase 3 (LAP3) and phosphoenolpyruvate carboxykinase mitochondrial (PCK2) were up-regulated significantly in HCC tissues with a capsule, compared to HCC tissues that broke the capsule.
CONCLUSION: These findings suggest that LAP3 and PCK2 could be factors responsible for the maintenance of encapsulation in HCC tissues. Copyright
© 2021, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  HCC; encapsulation; leucine aminopeptidase 3; phosphoenolpyruvate carboxykinase mitochondrial; proteomics

Mesh:

Substances:

Year:  2021        PMID: 33893083      PMCID: PMC8126332          DOI: 10.21873/cgp.20261

Source DB:  PubMed          Journal:  Cancer Genomics Proteomics        ISSN: 1109-6535            Impact factor:   4.069


  51 in total

Review 1.  Translational control of eIF5A in various diseases.

Authors:  Annette Kaiser
Journal:  Amino Acids       Date:  2011-08-05       Impact factor: 3.520

Review 2.  Clinical potential of matrix metalloprotease inhibitors in cancer therapy.

Authors:  E I Heath; L B Grochow
Journal:  Drugs       Date:  2000-05       Impact factor: 9.546

3.  Leucine aminopeptidase 3 promotes migration and invasion of breast cancer cells through upregulation of fascin and matrix metalloproteinases-2/9 expression.

Authors:  Chunyan Fang; Jian Zhang; Hanlin Yang; Lili Peng; Kun Wang; Yanjie Wang; Xin Zhao; Huijie Liu; Chunhui Dou; Lihong Shi; Chunling Zhao; Shujuan Liang; Daqi Li; Xuejian Wang
Journal:  J Cell Biochem       Date:  2018-11-11       Impact factor: 4.429

4.  Role of myofibroblasts in tumour encapsulation of hepatocellular carcinoma in haemochromatosis.

Authors:  K R Bridle; D H Crawford; L W Powell; G A Ramm
Journal:  Liver       Date:  2001-04

5.  Evidence that "myofibroblast-like" cells are the cellular source of capsular collagen in hepatocellular carcinoma.

Authors:  L P Ooi; D H Crawford; D C Gotley; A D Clouston; R W Strong; G C Gobe; J W Halliday; K R Bridle; G A Ramm
Journal:  J Hepatol       Date:  1997-04       Impact factor: 25.083

6.  Encapsulated hepatocellular carcinoma: CT-pathologic correlations.

Authors:  Jae Hoon Lim; Dongil Choi; Cheol Keun Park; Won Jae Lee; Hyo Keun Lim
Journal:  Eur Radiol       Date:  2006-03-18       Impact factor: 5.315

7.  A quantitative proteomic approach for identification of potential biomarkers in hepatocellular carcinoma.

Authors:  Raghothama Chaerkady; H C Harsha; Anuradha Nalli; Marjan Gucek; Perumal Vivekanandan; Javed Akhtar; Robert N Cole; Jessica Simmers; Richard D Schulick; Sujay Singh; Michael Torbenson; Akhilesh Pandey; Paul J Thuluvath
Journal:  J Proteome Res       Date:  2008-08-21       Impact factor: 4.466

Review 8.  Cellular Mechanisms of Circulating Tumor Cells During Breast Cancer Metastasis.

Authors:  Han-A Park; Spenser R Brown; Yonghyun Kim
Journal:  Int J Mol Sci       Date:  2020-07-17       Impact factor: 5.923

9.  Expression of RRBP1 in epithelial ovarian cancer and its clinical significance.

Authors:  Jing Ma; Sujing Ren; Jing Ding; Shuang Liu; Jiaqi Zhu; Rong Ma; Fanling Meng
Journal:  Biosci Rep       Date:  2019-07-23       Impact factor: 3.840

10.  Repurposing Cancer Drugs Batimastat and Marimastat to Inhibit the Activity of a Group I Metalloprotease from the Venom of the Western Diamondback Rattlesnake, Crotalus atrox.

Authors:  Harry J Layfield; Harry F Williams; Divyashree Ravishankar; Amita Mehmi; Medha Sonavane; Anika Salim; Rajendran Vaiyapuri; Karthik Lakshminarayanan; Thomas M Vallance; Andrew B Bicknell; Steven A Trim; Ketan Patel; Sakthivel Vaiyapuri
Journal:  Toxins (Basel)       Date:  2020-05-09       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.